- cafead Jul 08, 2021 at 11:12: AM
via Lilly will pay $25 million upfront and up to $694 million in biobucks for licensing rights to four potential programs from Verge Genomics, a San Francisco-based discovery outfit boasting an “all-in-human” discovery and development platform using AI to crunch through data from the biotech’s proprietary brain tissue database, the partners said.
article source
article source